Biomolecular Structure and Mechanism, Structure-Based Drug Design
Biomolecular Structure and Mechanism, Structure-Based Drug Design
批准号:
7732999
负责人:
XINHUA JI
金额:
$128.6万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ATP phosphohydrolaseBindingBinding SitesBiological AssayBiological ModelsCatalytic DomainCellsChemistryCisplatinComplexDNA-Directed RNA PolymeraseDevelopmentDimerizationDouble-Stranded RNADrug DesignDrug Metabolic DetoxicationElementsEnzymesExhibitsFamilyFamily memberFutureGene ExpressionGeneral Transcription FactorsGenetic TranscriptionGlutathione S-TransferaseGlutathione Transferase muHumanHydrolysisIn VitroIonsIsoenzymesKineticsLengthLiverMalignant NeoplasmsMediatingModelingModificationNitric OxideNucleotidesObject AttachmentPersonal SatisfactionPlayProcessProdrugsPropertyProtein IsoformsProtein OverexpressionProteinsRNARNA InterferenceRNA ProcessingRNA polymerase sigma 70ReactionRecyclingReportingRibonuclease IIIRoleShapesSmall Interfering RNAStructureanticancer activityantimicrobial drugbasecancer cellcytotoxicdesignds-DNAendonucleaseenzyme mechanismhuman DICER1 proteinin vivomembernovelphosphodiesterprotein foldingresearch studystructural biologytranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
RNA interference is mediated by small interfering RNAs produced by members of the ribonuclease III (RNase III) family, including Dicer. For mechanistic studies, bacterial RNase III has been a valuable model system for the entire family. Previously, we have shown how the dimerization of the endonuclease domain of the enzyme creates a catalytic valley where two catalytic sites are located, how the catalytic valley accommodates a dsRNA in a manner such that each of the two RNA strands is aligned with one of the two catalytic sites, how the hydrolysis of each strand involves both subunits (residues from one subunit are involved in the selection of the scissile bond, while those from the partner subunit are involved in the cleavage chemistry), and how RNase III uses the two catalytic sites to create the 2-nucleotide 3' overhangs in its products. Recently, we have demonstrated how Mg2+ is essential for the formation of a catalytically competent protein-RNA complex, how the use of two Mg2+ ions can drive the hydrolysis of each phosphodiester bond, and how conformational changes in both the substrate and the protein are critical elements for assembling the catalytic complex. Moreover, we have modeled a protein-substrate complex and a protein-reaction intermediate (transition state) complex in a meaningful way. Together, the models and crystal structures suggest a stepwise mechanism for the enzyme to execute the phosphoryl transfer reaction. The structural information of protein-dsRNA interactions and the mechanism of dsRNA processing by bacterial RNase III can be extrapolated to other family members, including eukaryotic Rnt1p, Drosha and Dicer. RapA, as abundant as sigma 70 in the cell, is an RNA polymerase (RNAP)-associated Swi2/Snf2 protein with ATPase activity. It stimulates RNAP recycling during transcription. Recently, we reported the first structure of RapA, which is also the first full-length structure for the entire Swi2/Snf2 family. RapA contains seven domains, two of which exhibit novel protein folds. Our model of RapA in complex with ATP and double-stranded (ds) DNA suggests that RapA may bind to and translocate on dsDNA. Our kinetic template-switching assay shows that RapA facilitates the release of sequestered RNAP from a posttranscrption/posttermination complex (PTC) for transcription reinitiation. Our in vitro competition experiment indicates that RapA binds to core RNAP only but is readily displaceable by sigma 70. RapA is likely another general transcription factor, the structure of which provides a framework for future studies of this bacterial Swi2/Snf2 protein and its important roles in RNAP recycling during transcription. Glutathione S-transferase (GST) is a superfamily of detoxification enzymes, represented by GST-alpha, GST-mu, GST-pi, etc. GST-alpha is the predominant isoform of GST in human liver, playing important roles for our well being. GST-pi is overexpressed in many forms of cancer, thus presenting an opportunity for selective targeting of cancer cells. Our structure-based design of prodrugs intended to release cytotoxic levels of nitric oxide in GST-pi-overexpressing cancer cells yielded PABA/NO, which exhibited anticancer activity both in vitro and in vivo with a potency similar to that of cisplatin. The design was based on GST structures at both ground state and transition state. The ground-state structures outlined the shape and property of the substrate-binding site in different isozymes, and the structural information at the transition-state provided guidance for structural modifications of the prodrug molecules. Two key alterations of a GST-alpha-selective compound led to the GST-pi-selective PABA/NO.RNA interference is mediated by small interfering RNAs produced by members of the ribonuclease III (RNase III) family, including Dicer. For mechanistic studies, bacterial RNase III has been a valuable model system for the entire family. Previously, we have shown how the dimerization of the endonuclease domain of the enzyme creates a catalytic valley where two catalytic sites are located, how the catalytic valley accommodates a dsRNA in a manner such that each of the two RNA strands is aligned with one of the two catalytic sites, how the hydrolysis of each strand involves both subunits (residues from one subunit are involved in the selection of the scissile bond, while those from the partner subunit are involved in the cleavage chemistry), and how RNase III uses the two catalytic sites to create the 2-nucleotide 3' overhangs in its products. Recently, we have demonstrated how Mg2+ is essential for the formation of a catalytically competent protein-RNA complex, how the use of two Mg2+ ions can drive the hydrolysis of each phosphodiester bond, and how conformational changes in both the substrate and the protein are critical elements for assembling the catalytic complex. Moreover, we have modeled a protein-substrate complex and a protein-reaction intermediate (transition state) complex in a meaningful way. Together, the models and crystal structures suggest a stepwise mechanism for the enzyme to execute the phosphoryl transfer reaction. The structural information of protein-dsRNA interactions and the mechanism of dsRNA processing by bacterial RNase III can be extrapolated to other family members, including eukaryotic Rnt1p, Drosha and Dicer. RapA, as abundant as sigma 70 in the cell, is an RNA polymerase (RNAP)-associated Swi2/Snf2 protein with ATPase activity. It stimulates RNAP recycling during transcription. Recently, we reported the first structure of RapA, which is also the first full-length structure for the entire Swi2/Snf2 family. RapA contains seven domains, two of which exhibit novel protein folds. Our model of RapA in complex with ATP and double-stranded (ds) DNA suggests that RapA may bind to and translocate on dsDNA. Our kinetic template-switching assay shows that RapA facilitates the release of sequestered RNAP from a posttranscrption/posttermination complex (PTC) for transcription reinitiation. Our in vitro competition experiment indicates that RapA binds to core RNAP only but is readily displaceable by sigma 70. RapA is likely another general transcription factor, the structure of which provides a framework for future studies of this bacterial Swi2/Snf2 protein and its important roles in RNAP recycling during transcription. Glutathione S-transferase (GST) is a superfamily of detoxification enzymes, represented by GST-alpha, GST-mu, GST-pi, etc. GST-alpha is the predominant isoform of GST in human liver, playing important roles for our well being. GST-pi is overexpressed in many forms of cancer, thus presenting an opportunity for selective targeting of cancer cells. Our structure-based design of prodrugs intended to release cytotoxic levels of nitric oxide in GST-pi-overexpressing cancer cells yielded PABA/NO, which exhibited anticancer activity both in vitro and in vivo with a potency similar to that of cisplatin. The design was based on GST structures at both ground state and transition state. The ground-state structures outlined the shape and property of the substrate-binding site in different isozymes, and the structural information at the transition-state provided guidance for structur [summary truncated at 7800 characters]
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2147/dddt.s3931
发表时间:
2008
期刊:
Drug design, development and therapy
影响因子:
--
作者:
[Ji X, Pal A, Kalathur R, Hu X, Gu Y, Saavedra JE, Buzard GS, Srinivasan A, Keefer LK, Singh SV]
通讯作者:
Singh SV
DOI:
10.1074/jbc.m600697200
发表时间:
2006-06-09
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS]
通讯作者:
Dimitrov DS
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
通过具有交叉反应性的 HIV-1 中和抗体与含有独特基序的 CDR-H2 和 H3 来模拟 CD4。
DOI:
10.1016/j.jmb.2005.12.062
发表时间:
2006
期刊:
Journal of molecular biology
影响因子:
5.6
作者:
[Prabakaran,Ponraj, Gan,Jianhua, Wu,You-Qiang, Zhang,Mei-Yun, Dimitrov,DimiterS, Ji,Xinhua]
通讯作者:
Ji,Xinhua
The mechanism of RNase III action: how dicer dices.
RNase III 作用机制:切丁机如何切丁。
DOI:
10.1007/978-3-540-75157-1_5
发表时间:
2008
期刊:
Current topics in microbiology and immunology
影响因子:
--
作者:
[Ji,Xinhua]
通讯作者:
Ji,Xinhua
CRYSTAL STRUCT OF ERA GTPASE DEPENDENT CELL CYCLE REGULATOR W/ RNA BINDING MOTIF
-
批准号:6205774
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:XINHUA JI
-
依托单位:
SYNCHROTRON CRYSTALLOGRAPHY OF GTPASES & GUANYLATE KINASES
-
批准号:6120419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:XINHUA JI
-
依托单位:
SYNCHROTRON CRYSTALLOG OF 7,8 DIHYDRO 6 HYDROXYMETHYLPTERIN PYROPHOSPHOKINASE
-
批准号:6120420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:XINHUA JI
-
依托单位:
Structural Chemistry of Biomolecular Systems and Structu
-
批准号:7338457
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:7592663
-
项目类别:
-
资助金额:$133.18万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:8175306
-
项目类别:
-
资助金额:$143.46万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Structural of Biomolecular Systems by X Ray Diffraction
-
批准号:6559206
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:7965248
-
项目类别:
-
资助金额:$123.58万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:10702336
-
项目类别:
-
资助金额:$198.2万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:10926000
-
项目类别:
-
资助金额:$173.24万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:10014349
-
项目类别:
-
资助金额:$219.98万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:8552665
-
项目类别:
-
资助金额:$156.58万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:9343594
-
项目类别:
-
资助金额:$160.63万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Structural Chemistry of Biomolecular Systems by X-ray Di
-
批准号:6951339
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Structural Chem. of Biomolecular Sys. by X-ray Diffract.
-
批准号:7052397
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
STRUCTURAL CHEMISTRY OF BIOMOLECULAR SYSTEMS
-
批准号:6419874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:8937709
-
项目类别:
-
资助金额:$191.74万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:8348975
-
项目类别:
-
资助金额:$135.04万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:10262068
-
项目类别:
-
资助金额:$225.38万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
Biomolecular Structure and Mechanism, Structure-Based Drug Design
-
批准号:8763074
-
项目类别:
-
资助金额:$146.32万
-
财政年份:--
-
负责人:XINHUA JI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: